What is the appropriate emergency department (ED) management for urticaria (rash/hives) in a pregnant patient?

Emergency Department Management of Urticaria in Pregnancy

For pregnant patients presenting to the ED with urticaria, initiate treatment with standard-dose second-generation H1-antihistamines, specifically chlorphenamine (chlorpheniramine), loratadine, or cetirizine, as these have the best safety profiles in pregnancy. 1

First-Line Treatment Approach

Start with second-generation H1-antihistamines at standard doses:

• Chlorphenamine (chlorpheniramine) is most commonly chosen in clinical practice due to its long safety record, despite being technically a first-generation agent 1
• Loratadine and cetirizine are FDA Pregnancy Category B drugs (no evidence of fetal harm, though controlled human studies are lacking) 1
• These medications can be given immediately in the ED and continued as outpatient therapy

Critical caveat: While guidelines state it's "best to avoid all antihistamines in pregnancy, especially during the first trimester," none have been shown to be teratogenic in humans. The risk-benefit analysis favors treatment when urticaria is symptomatic 1. Real-world data from the PREG-CU study showed that 60% of pregnant CU patients used urticaria medications during pregnancy with no increased rates of medical problems in newborns 2.

Dose Escalation Strategy

If symptoms are intolerable or inadequately controlled:

• Increase the second-generation H1-antihistamine dose up to 4-fold 3
• This approach is safe during pregnancy based on recent evidence 2, 4
• Do not delay escalation if standard doses are ineffective—prolonged inadequate control increases risk of emergency referrals, which are associated with preterm birth 2

Additional ED Interventions

For Acute Severe Urticaria:

• Short-course oral corticosteroids may be used (e.g., prednisolone 50 mg daily for 3 days, though lower doses are often effective) 1
• Parenteral hydrocortisone can be given in the ED for severe presentations 1

For Anaphylaxis or Severe Laryngeal Angioedema:

• Intramuscular epinephrine 0.5 mL of 1:1000 (500 µg) is life-saving and should not be withheld in pregnancy 1
• Use with caution in hypertension and ischemic heart disease
• Repeat dosing if no significant symptom relief after first dose

Medications to AVOID in Pregnancy

Hydroxyzine is specifically contraindicated in early pregnancy 1—do not prescribe this commonly used urticaria medication to pregnant patients.

Other antihistamines to avoid or use with extreme caution:

• Alimemazine (hepatotoxic, can precipitate coma in liver disease)
• Mizolastine (contraindicated in hepatic impairment)

Discharge Planning

Patient Education:

• Avoid nonspecific triggers: overheating, stress, alcohol
• Avoid NSAIDs and aspirin if urticaria worsens with these agents 1
• Avoid ACE inhibitors if angioedema is present 1
• Cooling lotions (calamine, 1% menthol in aqueous cream) for symptomatic relief 1

Follow-up:

• Arrange outpatient follow-up if symptoms persist beyond 6 weeks (chronic urticaria)
• Emphasize importance of adequate disease control—emergency referrals for urticaria during pregnancy are a risk factor for preterm birth 2
• Consider specialist referral if refractory to up-dosed antihistamines

Special Considerations

The PREG-CU study (288 pregnant CU patients across 13 countries) provides reassuring real-world data:

• Preterm birth rate was 10.2% (similar between treated and untreated patients: 11.6% vs 8.7%)

• 90% of newborns were healthy at birth

• No link between urticaria treatments and medical problems at birth 2

Omalizumab, while not typically initiated in the ED, has emerging safety data in pregnancy. Recent studies show no adverse maternal or fetal outcomes when used before or during pregnancy 5, though this would be a specialist-initiated therapy.

Key Pitfalls to Avoid

1. Do not prescribe hydroxyzine—it's the only antihistamine specifically contraindicated in early pregnancy
2. Do not delay treatment escalation—inadequate control leads to emergency visits that increase preterm birth risk
3. Do not withhold epinephrine in anaphylaxis due to pregnancy concerns—maternal mortality risk far outweighs theoretical fetal risks
4. Do not use long-term corticosteroids for chronic urticaria management (only short courses for acute flares)